Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients

H Osawa, N Nakamura, C Tsutaya, H Saitoh… - in vivo, 2024 - iv.iiarjournals.org
Background/Aim: The pathogenesis of cardio-vascular disease (CVD) in hemodialysis (HD)
patients involves inflammation and oxidative stress. High-sensitivity C-reactive protein (hs …

Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients.

H Osawa, N Nakamura, C Tsutaya, H Saitoh… - In Vivo (Athens …, 2024 - europepmc.org
Results We observed 44 CV events during the median follow-up period of 743 days. The
event-free survival rate significantly differed between the two groups in hs-CRP but not in …

Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients

H Osawa, N Nakamura, C Tsutaya… - In vivo (Athens …, 2024 - pubmed.ncbi.nlm.nih.gov
Background/aim The pathogenesis of cardio-vascular disease (CVD) in hemodialysis (HD)
patients involves inflammation and oxidative stress. High-sensitivity C-reactive protein (hs …

[PDF][PDF] Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients

H OSAWA, N NAKAMURA, C TSUTAYA, H SAITOH… - in vivo, 2024 - iv.iiarjournals.org
Background/Aim: The pathogenesis of cardiovascular disease (CVD) in hemodialysis (HD)
patients involves inflammation and oxidative stress. High-sensitivity C-reactive protein (hs …

Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients.

H OSAWA, N NAKAMURA, C TSUTAYA, H SAITOH… - In …, 2024 - search.ebscohost.com
Abstract Background/Aim: The pathogenesis of cardiovascular disease (CVD) in
hemodialysis (HD) patients involves inflammation and oxidative stress. High-sensitivity C …

[HTML][HTML] Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients

H OSAWA, N NAKAMURA, C TSUTAYA, H SAITOH… - In Vivo, 2024 - ncbi.nlm.nih.gov
Results We observed 44 CV events during the median follow-up period of 743 days. The
event-free survival rate significantly differed between the two groups in hs-CRP but not in …

Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients.

H Osawa, N Nakamura, C Tsutaya, H Saitoh… - In Vivo (Athens …, 2024 - europepmc.org
Results We observed 44 CV events during the median follow-up period of 743 days. The
event-free survival rate significantly differed between the two groups in hs-CRP but not in …